Tak 653 Nootropic Powder

Xi'an Sonwu Biotech Co., Ltd. focuses on the supply of pharmaceutical raw materials, anti-hair loss products, peptides, weight management solutions, and plant extracts. Xi'an Sonwu are committed to providing high-quality ingredients and reliable sourcing solutions to global clients, meeting the diverse needs of the pharmaceutical, nutraceutical, cosmetic, and health industries.

Regarding the product TAK 653, Xi'an Sonwu offers not only the raw material but also a range of customized services; many of our clients purchase TAK 653 in capsule form for research purposes.

Xi'an Sonwu provides shipping services to various regions worldwide, utilizing carriers such as specialized shipping lines, DHL, UPS, EMS, and FedEx. For shipments to the United States and Europe, for instance, we offer a specialized "door-to-door" shipping service that includes customs clearance and is duty-free; the typical transit time is approximately 15 days. When arranging shipments, we adjust the product description and the declared value to ensure a smoother delivery process for our clients.

Xi'an Sonwu not only supplies high-quality TAK-653, but can also customize products according to customer needs. In addition, Sonwu can provide customized packaging services, including repackaging products according to customer requirements.

1. Customized capsules shells (size, color, material)

2. Customized bottles(size, color, material, style)

3. Customized packaging(vacuum foil packaging, box, drum)

4. Customized label(paint film, matte film, optical mask)

TAK-653 is not a typical peptide, plant extract, or weight-loss ingredient; rather, it is an experimental active compound currently under development as a pharmaceutical agent.

1. Pharmacological Profile

Positive allosteric modulator of the AMPA receptor.

REFERENCE: Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement.

2. Research Applications

Studies in neuropharmacology, synaptic function, cortical excitability, and the mechanisms underlying antidepressant effects.

REFERENCE: Transcranial magnetic stimulation as a translational biomarker for AMPA receptor modulation.

TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.

3. Evidence Base

Pharmacodynamic studies conducted in cells, animal models, and healthy human subjects.

REFERENCE: Central nervous system effects of TAK-653, an investigational alpha-amino-3-hydroxy-5-methyl-4-isoxazole receptor (AMPAR) positive allosteric modulator in healthy volunteers.

TAK-653 (generic name: Osavampator) is characterized by minimal direct agonist activity; it amplifies AMPA receptor signaling only when endogenous glutamate is released, slows receptor desensitization, upregulates BDNF, and promotes synaptic plasticity.

AMPA receptors are among the primary excitatory glutamate receptors in the central nervous system. They mediate rapid synaptic transmission and are closely linked to learning, memory, and synaptic plasticity. TAK-653 is unique due to its "extremely low intrinsic agonist activity":

1. Glutamate-dependent binding: It binds stably to the dimer interface of the GluA2 subunit's ligand-binding domain (LBD) only when the receptor has already adopted a conformation induced by glutamate binding. In the resting state-absent glutamate-it shows negligible binding, ensuring it does not "idly" activate resting receptors.
2. "Molecular wedge" mechanism: The compound acts like a wedge inserted into the dimer interface. Through steric hindrance-facilitated by its cyclohexyl side chain at the Ser750/Ser743 sites-it stabilizes the receptor's conformation and delays desensitization. This amplifies the AMPA currents triggered by the physiological release of glutamate.
3. Downstream signaling: In primary cortical neurons, TAK-653 significantly enhances AMPA-induced calcium influx and electrical currents. It also promotes the phosphorylation of Akt, ERK, mTOR, and p70S6 kinase, while increasing BDNF levels-a downstream pathway similar to that of the rapid-acting agent ketamine.
In simpler terms: while traditional enhancers act like "pressing the gas pedal," TAK-653 functions more like "tuning the throttle response"-it boosts power only when the pedal is pressed (i.e., when glutamate arrives), without wasting energy while the system is at rest.

Q:Are you supplier or manufacturer of TAK 653?

A:Yes, we are the manufacturer.

Q:How do you ensure TAK 653 quality?

A:Before the products are shipped out, we will conduct tests to ensure that the purity meets the standards and provide COA (Certificate of Analysis).

Q:What is your TAK 653 minimum order quantity (MOQ)?

A:1gram

Q:Do you accept sample orders?

A:yes

Q:Do you offer TAK 653 customized packaging services?

A:Yes, we offer customized labels as well as customized packaging services.

Xi'an Sonwu Biotech Co., Ltd. is a manufacturer of peptide-based raw materials, focused on peptide technology and serving the international market. Xi'an Sonwu specialize in the R&D, production, and global supply of functional peptides and peptide raw materials. Our products are widely used in various sectors, including fitness, beauty, hair growth, weight management, pharmaceuticals, and blood sugar regulation.

Besides guaranteeing the product, the most important thing is that customers receive the goods smoothly. So, Xi'an Sonwu offers a range of couriers to meet different needs.

Hot Tags: tak 653 nootropic powder, China tak 653 nootropic powder manufacturers, suppliers, factory, 99 N Acetyl Taurine Powder, Crl 40 941 Powder, nootropics peptieds, Pinealon Powder, Selank Powder